Royal Canin Just Moved Into Supplements

Royal Canin built its reputation on one thing: food. Precise, science-driven, breed- and condition-specific food that veterinarians have recommended for decades because the formulations are backed by real research. For most of the company's history, that was the full scope of what they offered.

That changed in 2025 when Royal Canin launched its first supplements and probiotics line, a move that represents a meaningful shift for a brand that has historically stayed in its lane. The question worth asking is not whether the branding is impressive, it always is, but what the products actually contain and whether the science behind them holds up to the same standard the company has applied to its diets.

Here is a plain-language breakdown of what is in each product and what the clinical rationale is.

THE PROBIOTIC: ONE STRAIN, ONE JOB

The probiotic powder for cats and dogs is built around a single strain: Saccharomyces boulardii CNCM I-1079. This is not a marketing strain. S. boulardii is a yeast-based probiotic with a reasonably well-documented body of research behind it, including studies in dogs showing benefits for acute diarrhea, antibiotic-associated diarrhea, and gut microbiome support. The CNCM I-1079 designation refers to the specific strain deposited with the Pasteur Institute, which matters because probiotic efficacy is strain-specific and not all S. boulardii products are the same.

The formula is designed to support immune function and digestive health, which is consistent with the published literature on this strain. Using a single, well-characterized strain rather than a multi-strain blend is a defensible formulation choice, particularly for a product targeting a clinical population where consistency of effect matters.

Available in 7-count and 30-count boxes for both species.

THE SOFT CHEWS: FOUR FORMULAS, FOUR TARGET AREAS

Royal Canin is offering four soft chew products for dogs, one for puppies and three for adults, each targeting a common area of clinical concern.

A single, well-characterized probiotic strain over a multi-strain blend is a defensible formulation choice. It signals that the goal is clinical consistency, not label impressiveness.

PUPPY DIGESTIVE AND IMMUNE HEALTH

The puppy formula combines prebiotic fibers for microbiome support, vitamins E and C for cellular and immune health, and beta-glucan postbiotics for digestive health and stool quality. Postbiotics, the bioactive compounds produced during fermentation, have emerging but growing research support. Including them in a puppy formulation is a forward-leaning ingredient choice that reflects where the gut health literature is moving.

ADULT DIGESTIVE CHEWS

Similar prebiotic and beta-glucan postbiotic base as the puppy formula, with the addition of zeolite for stool odor reduction. Zeolite is a mineral with documented ammonia-binding properties, which is the mechanism behind its odor effect. It is not a novel ingredient but it is appropriately applied here.

JOINT CHEWS

Formulated with New Zealand green-lipped mussel and EPA plus DHA. Green-lipped mussel has been studied for joint health in dogs specifically, with several trials showing modest but real effects on mobility and comfort. The EPA and DHA addition addresses the inflammatory component of joint disease, which is the pathway where omega-3 fatty acids have their most documented effect in veterinary patients. This is a credible combination for a maintenance-level joint supplement, not a therapeutic replacement for NSAIDs or other interventions in moderate to severe disease.

SKIN AND COAT CHEWS

The skin and coat formula includes GLA (gamma-linolenic acid), LA (linoleic acid), zinc, EPA, DHA, and a B-vitamin blend. This is a fairly complete essential fatty acid and micronutrient approach to skin barrier support. GLA and LA are omega-6 fatty acids that play a direct role in maintaining skin hydration and barrier function. The B-vitamin inclusion, particularly biotin, is clinically relevant for coat quality. Zinc deficiency is a documented cause of skin changes in dogs, making its inclusion appropriate even in patients without frank deficiency.

THE BROADER PICTURE

The supplement market for pets is enormous, largely unregulated in terms of efficacy claims, and full of products with impressive packaging and thin science. Royal Canin entering this space with formulations that appear to be grounded in published research rather than trend ingredients is meaningful, not because it automatically makes these products superior, but because it raises the floor on what a credible supplement offering looks like from a brand that veterinarians already trust.

The clinical utility of any supplement depends on the individual patient, the underlying condition, and what else is already in the treatment plan. None of these products are designed to replace therapeutic nutrition or prescription management. They are positioned as additions to an already balanced diet, which is the appropriate framing.

Where these products will most likely earn a place in practice is in the conversation with owners who are already buying supplements from retail channels with less rigorous formulations. Redirecting that client toward something with documented ingredients and a brand with a veterinary track record is a defensible recommendation.

The supplement market is enormous and largely unregulated. A brand with a veterinary track record entering it with documented ingredients raises the floor for everyone.

Royal Canin's supplements and probiotics are available through Chewy, Amazon, and veterinary practices. Full ingredient and formulation details at royalcanin.com/us/supplements and royalcanin.com/us/probiotics.

Royal Canin is a division of Mars, Incorporated. Founded in 1968 by French veterinarian Dr. Jean Cathary. Reporting by Vet Candy | myvetcandy.com